SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

GSI Technology, Inc. engages in the design, development and marketing of memory products primarily for the networking, and telecommunications markets. Its product includes Static Random Access Memory, or SRAM, which incorporated in networking and telecommunications equipment, such as routers, switches, wide area network infrastructure equipment, wireless base stations and network access equipment. It also offers services to the ongoing needs of the military, industrial, test and measurement equipment, automotive and medical markets for SRAMs .The company was founded by Lee-Lean Shu and Robert Yau in March 1995 and is headquartered in Sunnyvale, CA.

GSI Technology Inc

GSIT is trending due to a Cornell University study highlighting its APU's comparable GPU performance with significantly lower energy consumption, sparking discussions about its potential to disrupt the AI inference market and compete with major players like NVDA. The community is actively debating the implications of this technology, potential market share, and possible acquisition scenarios. Additionally, some traders are closely monitoring potential short squeezes.

Amazon.com, Inc. is a multinational technology company, which engages in the provision of online retail shopping services. It operates through the following segments: North America, International, and Amazon Web Services (AWS). The North America segment offers retail sale of consumer products, including from sellers, advertising, and subscriptions services through North America-focused online and physical stores. The International segment focuses on retail sale of consumer products, including from sellers, advertising, and subscription services through internationally-focused online stores. The AWS segment is composed of global sales of compute, storage, database, and other services for start-ups, enterprises, government agencies, and academic institutions. The company was founded by Jeffrey P. Bezos in July 1994 and is headquartered in Seattle, WA.

Amazon.com Inc.

Amazon.com Inc

Amazon is trending due to a widespread AWS outage impacting numerous websites and applications, sparking community discussion about the company's infrastructure and potential lawsuits. Despite the service disruption, the stock price saw an increase, fueling debates about market dynamics and AWS's overall importance. Some investors believe the outage highlights the world's dependence on Amazon, while others anticipate a negative impact on earnings and a potential shift to alternative cloud providers.

CorMedix, Inc. is a pharmaceutical and medical device company, which engages in the development and commercialization of therapeutic products for the prevention and treatment of diseases and conditions. The company was founded by Antony E. Pfaffle on July 28, 2006 and is headquartered in Berkeley Heights, NJ.

CorMedix Inc

CorMedix is trending due to recent positive preliminary Q3 results and raised FY2025 revenue guidance, sparking community discussion around a potential short squeeze given the high short interest. Some investors speculate about a possible acquisition by larger pharmaceutical companies and the potential impact of CorMedix's investment in TLPH, while others focus on the upcoming earnings report and potential catalysts.

Zions Bancorporation NA is a bank holding company, which engages in the provision of full banking and related services. It operates through the following segments: Zions Bank, Amegy Bank, California Bank & Trust, National Bank of Arizona, Nevada State Bank, Vectra Bank Colorado, and The Commerce Bank of Washington. The company was founded on February 17, 1961, and is headquartered in Salt Lake City, UT.

Zions Bancorporation N.A

Zions Bancorp is trending due to Q3 earnings exceeding expectations, with investors seemingly shrugging off a prior charge-off tied to bad loans that previously rattled the market. The community is actively discussing the bank's bounce-back, with some analysts suggesting the selloff was overdone, while others highlight concerns about credit risks in the broader regional banking sector. Community members are watching ZION's ability to maintain its credit without concerns of risk weighted assets and charge offs.

FLOKI is the utility token of the Floki Ecosystem. The Floki Ecosystem is a community-powered ecosystem that aims to give people control of their finances through four key utility offerings:  - The Valhalla NFT Metaverse Game. - The Floki University Crypto Education platform. - DeFi. - The FlokiPlaces NFT & Merchandise Marketplace.

Floki Token

FLOKI is trending due to its recent listing on Robinhood, sparking excitement within the community about increased accessibility and potential price surge. Community members are drawing comparisons to DOGE and SHIB, while anticipating a potential rally. Some traders are actively scalping the volatility, while longer-term holders express optimism about the future.

Cleveland-Cliffs, Inc. is a flat-rolled steel company, which engages in provision of iron ore pellets to the North American steel industry. It focuses on the production of metallic and coke, iron making, steelmaking, rolling and finishing, and downstream tubular components, stamping, and tooling. The company was founded in 1847 and is headquartered in Cleveland, OH.

Cleveland-Cliffs Inc

Cleveland-Cliffs is trending as traders react to news of the company exploring rare earth mineral production, overshadowing a revenue miss. The community is focused on the potential shift from steel to strategic minerals, and the implications for the company's future. Some traders express caution, citing debt and past performance, while others see the rare earth pivot and potential government support as bullish signals.

Replimune Group, Inc. is a clinical-stage biotechnology company. It engages in the business of developing oncolytic immunotherapies for the treatment of cancer. The company was founded by Philip Astley-Sparke, Colin A. Love, and Robert Coffin in March 2015 and is headquartered in Woburn, MA.

Replimune Group Inc

Replimune is trending due to discussions around its FDA Biologics License Application resubmission for RP1 in advanced melanoma, with a PDUFA date set for April 2026, leading to both bullish and bearish sentiment. Community talking points include the potential for a pump and dump, comparisons to similar situations with other stocks, and speculation about future funding. The stock's high volatility and a significant short interest are also contributing to the heightened interest.

AlphaVest Acquisition Corp. is a blank check company, which engages in effecting a merger, stock exchange, asset acquisition, stock purchase, and reorganization or similar business combination. The company was founded on January 14, 2022 and is headquartered in New York, NY.

AlphaVest Acquisition Corp

ATMV is trending due to its acquisition news and status as a micro-float stock, leading to significant price volatility. The community is actively discussing its potential for further gains and the possibility of a short squeeze, while also cautioning about potential risks associated with halts and price manipulation. Some traders are highlighting the potential merger with Wanshun Technology Industrial Group Limited.

Storing value in digital art. Project launched by famous Korean artist with 144k instagram followers and millions of interactions. Created a token behind his digital art character ‘CUTIE’. The crypto community on X decided to support the artist by sharing his work to wider audiences. The artist is affiliated with some renowned names that have established and successful projects in the crypto space such as the artist behind $nub the silly nub cat.

Cute Style

CUTIE is trending as traders discuss its chart appearance and potential entry points. Community members are sharing links to charts and expressing bullish sentiment, while some traders suggest caution despite following signals from experienced investors. The conversation highlights interest in CUTIE's momentum and recent price action.

Galaxy Digital, Inc. engages in digital assets and data center infrastructure, delivering solutions that accelerate progress in finance and artificial intelligence. It operates through the following segments: Digital Assets and Data Centers. The digital assets segment offers institutional access to trading, advisory, asset management, staking, self-custody, and tokenization technology. The Data Centers segment competes with a range of infrastructure providers that are building or repurposing facilities to support the rapidly growing demand for AI and compute-intensive workloads. The company was founded by Michael Novogratz in 2018 and is headquartered in New York, NY.

Galaxy Digital Inc. - Ordinary Shares - Class A

Fueled by anticipation for upcoming earnings and a recently announced $460 million strategic investment, Galaxy Digital is trending as the community debates the potential impact of these catalysts. Some investors express concerns about dilution and broader market conditions, while others remain bullish, highlighting the company's AI data center initiatives and crypto market positioning. Many are also speculating on the identity of the 'leading asset management firm' behind the investment.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

<ul class="summary-bullets"><li>GRAIL plans to raise about $325 million through a private placement involving both new and existing institutional investors.</li><li>The deal includes issuing over 4.6 million shares at $70.05 each, with closing expected on Oct. 21, 2025.</li><li>The funds will support commercial expansion, reimbursement initiatives, and general corporate purposes.&nbsp;</li></ul>GRAIL, Inc. (GRAL) announced on Monday that it has entered into a securities purchase agreement for a private placement to bring in approximately $325 million in gross proceeds to support its growth and commercialization efforts.As part of the deal, the company will issue 4.6 million shares of common stock, or pre-funded warrants, at $70.05 per share. Each pre-funded warrant carries a nominal exercise price of $0.001.<a href="https://stocktwits.com/symbol/GRAL">GRAIL stock</a> traded over 12% higher in Monday’s premarket. On Stocktwits, retail sentiment around the stock remained in ‘bullish’ territory amid ‘high’ message volume levels.&nbsp;<h2 class="st-heading-2">Institutional Investors Back Private Placement</h2>The healthcare company’s agreement involves both fresh and existing institutional backers. The company expects the deal to close on Oct. 21, 2025, pending customary closing requirements.&nbsp;<h2 class="st-heading-2">Funding Expected To Extend Operations Through 2030</h2>GRAIL intends to use the net proceeds toward commercial expansion, reimbursement initiatives, and day-to-day operational needs. This fresh injection of capital, combined with $127.4 million in cash and equivalents as of June end, is projected to sustain its planned operations well into 2030.&nbsp;This forecast does not include a separate $110 million investment agreement from Samsung C&amp;T and Samsung Electronics.Additionally, GRAIL and the University of Oxford released updated registry results from the SYMPLIFY study, which monitored more than 6,000 individuals over two years. The study evaluated a multi-cancer early detection (MCED) test called Galleri in primary care settings.&nbsp;The test’s positive predictive value (PPV) stood at 75.5%, with its ability to accurately pinpoint the Cancer Signal Origin (CSO) in 84.8% of cases.GRAIL stock traded over 336% in 205 and over 438% in the last 12 months.&nbsp;Also See:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/apple-s-i-phone-17-sales-off-to-robust-start-report/ch6ClGMR3oY">Apple’s iPhone 17 Sales Off To Robust Start In Key Markets With Momentum Continuing Into October: Report</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Rising stock market chart on a trading board background.

Why Is GRAL Stock Rising Today?

GRAIL plans to raise about $325 million through a private placement involving both new and existing institutional investors.

Equity

GRAIL PATHFINDER 2 Results Show Galleri Multi-Cancer Early Detection Blood Test Increased Cancer Detection More Than Seven-Fold When Added to USPSTF A and B Recommended Screenings

GRAIL PATHFINDER 2 Results Show Galleri Multi-Cancer Early Detection Blood Test Increased Cancer Detection More Than Seven-Fold When Added to USPSTF A and B Recommended Screenings GRAIL PATHFINDER 2...

Precision Oncology Approaches Drive $312B Market Transformation

Precision Oncology Approaches Drive $312B Market Transformation Precision Oncology Approaches Drive $312B Market Transformation PR Newswire VANCOUVER, Oct. 17, 2025 USA News Group News Commentary...

Samsung and GRAIL Announce Strategic Collaboration to Bring GRAIL's Galleri Multi-Cancer Early Detection Test to Asia

Samsung and GRAIL Announce Strategic Collaboration to Bring GRAIL's Galleri Multi-Cancer Early Detection Test to Asia Samsung and GRAIL Announce Strategic Collaboration to Bring GRAIL's Galleri...

BioHarvest Sciences Inc. (BHST) Reports Q2 Loss, Misses Revenue Estimates

BioHarvest Sciences Inc. (BHST) delivered earnings and revenue surprises of -36.36% and -2.91%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Femasys Inc. (FEMY) Reports Q2 Loss, Lags Revenue Estimates

Femasys (FEMY) delivered earnings and revenue surprises of +11.11% and -48.88%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Lifecore Biomedical (LFCR) Reports Q4 Loss, Tops Revenue Estimates

Lifecore Biomedical (LFCR) delivered earnings and revenue surprises of -11.11% and +1.96%, respectively, for the quarter ended May 2025. Do the numbers hold clues to what lies ahead for the stock?

Stock Market News for May 23, 2025

GRAIL Partners With Actress Kate Walsh for Generation Possible to Raise Awareness of Multi-Cancer Early Detection Testing

GRAIL Partners With Actress Kate Walsh for Generation Possible to Raise Awareness of Multi-Cancer Early Detection Testing GRAIL Partners With Actress Kate Walsh for Generation Possible to Raise...

GRAIL to Present at TD Cowen 45th Annual Health Care Conference

GRAIL to Present at TD Cowen 45th Annual Health Care Conference GRAIL to Present at TD Cowen 45th Annual Health Care Conference PR Newswire MENLO PARK, Calif., Feb. 21, 2025 MENLO PARK, Calif., Feb...

GRAIL, Inc. operates as a commercial-stage healthcare company, which engages in the development of a technology for early detection of cancer. It utilizes machine learning, software, and automation to detect and identify multiple deadly cancer types in earlier stages. The company was founded by Jeffrey T. Huber, William H. Rastetter, Mostafa Ronaghi, and Richard D. Klausner on September 11, 2015 and is headquartered in Menlo Park, CA.

GRAIL Inc.

Will Netflix ($NFLX) beat quarterly earnings? 
 
*Powered by Polymarket

Stocktwits

Netflix Inc

) beat quarterly earnings? 
 
*Powered by Polymarket

Current Price	$91.85
Prev Close	$78.00
Open	$89.54
Dividend Yield	0.00%
50-Day Moving Average	$46.19
Beta	2.37
Avg. Volume	912,319.76
PE Ratio	-6.03

52-Week High	$89.57
52-Week Low	$12.76
Market Capitalization	$2.81B
EPS (Annual)	-$59.81
Price to Book	1.21
Revenue Per Employee	$125,595.00
Enterprise Value/EBITDA	N/A

GRAL
GRAIL Inc.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest GRAL News

GRALGRAIL Inc.